Smart Power System Co., Ltd.
Update：2025/01/01
Industries
Main Industry
Energy
Main Product/Service
AM BioTech specializes in the patented technology of bio-pulsed activation of stem cell exosomes, adeptly tailoring cell induction methods to specific demands and modifying exosome gene expression, with a dedicated team committed to the development and production of high-purity, high-quality induced bio-pulsed exosomes and related products for broad application in biopharmaceuticals, cancer diagnosis, scalp care, and medical aesthetics.
Do
Patented Bio-Pulsed Activation Technology
Utilizing patented technology to construct a microenvironment library for stem cell exosome production can enhance the specific effects of the Bio-Pulsed Exosomes by tens of times. The number of exosome vesicle particles is 1900 times higher. The protein content within the exosomes increased by 202%. And the miRNA (=μARN) content within the exosomes increased by 188%.
Exosome Ultra-Purification Extraction Technology
With the high-efficiency exosome ultra-purification extraction technology developed by AM Biotech, producing induced Bio-Pulsed Exosomes that meet medical, cosmetic, and hair growth needs with a purity of up to 99.99%.
Advanced Mass Production Process
Exclusive mass production technology can increase the production volume by more than 30 times per unit time. The reconstituted induced Bio-Pulsed Exosome lyophilized powder whose diameter of exosome particles remains within 200nm and keep consistent particle size, intact structure, and stable activity and quality.
High-Efficiency Exosome Production Technology
The lyophilized powder and its reconstituted solution can withstand room temperature for 2 years and high temperatures of 60°C for three days in stress tests. Our Bio-Pulsed Exosome can be stored at room temperature and maintaining their activity and efficacy stably.
Do
Patented Bio-Pulsed Activation Technology
Utilizing patented technology to construct a microenvironment library for stem cell exosome production can enhance the specific effects of the Bio-Pulsed Exosomes by tens of times. The number of exosome vesicle particles is 1900 times higher. The protein content within the exosomes increased by 202%. And the miRNA (=μARN) content within the exosomes increased by 188%.
Exosome Ultra-Purification Extraction Technology
With the high-efficiency exosome ultra-purification extraction technology developed by AM Biotech, producing induced Bio-Pulsed Exosomes that meet medical, cosmetic, and hair growth needs with a purity of up to 99.99%.
Advanced Mass Production Process
Exclusive mass production technology can increase the production volume by more than 30 times per unit time. The reconstituted induced Bio-Pulsed Exosome lyophilized powder whose diameter of exosome particles remains within 200nm and keep consistent particle size, intact structure, and stable activity and quality.
High-Efficiency Exosome Production Technology
The lyophilized powder and its reconstituted solution can withstand room temperature for 2 years and high temperatures of 60°C for three days in stress tests. Our Bio-Pulsed Exosome can be stored at room temperature and maintaining their activity and efficacy stably.
Founded Year
2019
Unified Business No.
82813602
Status
Active
Number of Employees
45
Total Paid-in
Capital
130,000,000 (NT$)
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, Ministry of Economic Affairs.
Location of Company
Taiwan
, New Taipei City
Exclusive content for members
Members-only content. Please log in to access.
Introduction
AM Biotech has gathered outstanding talents and resources from both the industrial and academic sectors. Under the
leadership of Dr. Richard Shieh, the technical team founded IRH Technology in 2015, focusing on stem cells and exosome
researches. In 2020, Ascension Medical Biotechnology Co. LTD.
was established, and we set up R&D and manufacturing laboratories that meet GMP standards and have achieved a leading position in technology within the industry.
AM Biotech specializes in the patented technology of bio-pulse activation of stem cell-derived exosomes. This involves a
adjusting the method of cellular induction according to needs, thereby altering the genetic expression of exosomes. The team is dedicated to developing and producing high-purity, high- quality induced bio-pulse exosomes and related products, which are widely used in biopharmaceuticals, cancer diagnosis, scalp care, and medical aesthetics.
Our team has invested significantly in R&D and collaborated with medical institutions and universities for clinical and efficacy trials, with the aim of enhancing human well-being and health confidence. In the future, we will continue to delve into new biotechnologies and exosome-based drug research and development. Creating new values in the biopharmaceutical field and advancing towards the global market.
leadership of Dr. Richard Shieh, the technical team founded IRH Technology in 2015, focusing on stem cells and exosome
researches. In 2020, Ascension Medical Biotechnology Co. LTD.
was established, and we set up R&D and manufacturing laboratories that meet GMP standards and have achieved a leading position in technology within the industry.
AM Biotech specializes in the patented technology of bio-pulse activation of stem cell-derived exosomes. This involves a
adjusting the method of cellular induction according to needs, thereby altering the genetic expression of exosomes. The team is dedicated to developing and producing high-purity, high- quality induced bio-pulse exosomes and related products, which are widely used in biopharmaceuticals, cancer diagnosis, scalp care, and medical aesthetics.
Our team has invested significantly in R&D and collaborated with medical institutions and universities for clinical and efficacy trials, with the aim of enhancing human well-being and health confidence. In the future, we will continue to delve into new biotechnologies and exosome-based drug research and development. Creating new values in the biopharmaceutical field and advancing towards the global market.
